AARP's Lobbying For Drug Cost Controls Gets Spotlight At House Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Subcommittee session serves as platform for advocacy group's pitch for closing the Medicare Part D coverage gap.